chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Temperature of 99.1F to 99.4F,  Caller says 3 hours later his temperature was 99.9F.; This is a spontaneous report from a contactable consumer (patient). A 68-years-old male patient received bnt162b2 PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: EM9810, Pfizer NTEC), via an unspecified route of administration in left arm on 04Feb2021 as 1st dose, single for covid-19 immunization. Medical history included diabetes, diagnosed 20 years ago, high cholesterol and abnormal blood pressure from an unknown date and unknown if ongoing. Concomitant medication included insulin, metformin taken for diabetes mellitus, rosuvastatin taken for blood cholesterol and hydrochlorothiazide, valsartan (VALSARTAN AND HYDROCHLOROTHIAZIDE) taken for blood pressure abnormal and amlodipine, patient stated that he has been taking these medications for about 20 years. Patient stated that he had his first shot on 04Feb2021 around 01:00PM and has got a fever next morning (05Feb2021). He says his highest temperature to date is 99.9 degrees Fahrenheit, which was about 30 minutes ago. He says he hadn't had a fever before. Patient stated that for his fever he took Ibuprofen. He said when he got up that morning (05Feb2021) it was 99.4 degrees Fahrenheit, and it went down to 99.1 degrees Fahrenheit, so he said ok and did not take Ibuprofen, then about two hours later it was 99.9 degrees Fahrenheit, so he took Ibuprofen 800mg. He says he was prescribed this to take one by mouth as needed for pain, he was taking Ibuprofen back in probably Mar2020 for walking pneumonia. The patient underwent lab tests and procedures which included pyrexia: 99.9 f on 05Feb2021, sars-cov-2 test: negative on 2020 (Unspecified date). Therapeutic measures were taken as a result of temperature of 99.1f to 99.4f,  caller says 3 hours later his temperature was 99.9f. The outcome for the event was unknown.  Follow-up attempts completed. No further information expected.
Information has been received from a physician concerning a 17 week old female with no pertinent medical history or drug allergies who on 02-NOV-2007 and 28-DEC-2007 was vaccinated PO with her first and second doses of RotaTeq (lot# 657459/0509U, 656387/0971U). There was no concomitant medication. On 28-DEC-2007 the patient experienced intussusception and was hospitalized on 03-JAN-2008. The intussusception was resolved with a barium enema. The patient did not require surgical interventions. On approximately 06-JAN-2008 2-3 days after hospitalization, the patient was discharged home and was noted to be recovered. On 14-JAN-2008 the patient was seen for a follow-up visit with the physician and her exam was normal. On that same day after the exam, therapy with RotaTeq was discontinued by the physician. There was no product quality complaint. Additional information has been requested.  01/25/2008 Vax record received and data entered. 01/29/2008 MR received for ER visit 1/3/08. Infant to ER with screaming, vomiting, and listlessness. No po intake that day.  Impression: Viral syndrome.  Vomiting. Child transfered to another facility for further care. 03/27/2008 MR received for DOS 01/4-6/2008 with D/C DX: Intussusception. Infant presented to local hospital with lethargy, decreased po intake and vomiting. Pt later had a bloody stool. IS noted on Abd US. Air contrast enema successful in reducing IS. Pt began taking PO well and became more alert and was d/c home.
This case was reported by a consumer (subject) and described the occurrence of hard to breath in a 46-year-old female subject who was vaccinated with Influenza vaccine unspecified (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject's medical history included thyroidectomy. Concurrent medical conditions included allergy to sulfa drugs, asthma and mycin allergy. The subject reported that she "has an allergy to mycin antibiotics" and that she received "a typhoid or cholera vaccination many years ago, which had a mycin in it", and "had a reaction like this" one that she reported on 17 October 2013. Concurrent medications included Simvastatin, Nexium, Janumet, VICTOZA, Cymbalta, Desipramine, Pro-Air and Advair. Co-suspect medication included Benadryl. On 17 October 2013 at 14:45 the subject received a of Influenza vaccine unspecified (unknown details, left arm). The subject knew she received a "GSK flu vaccine" but was unsure of which formulation. On the night of 17 October 2013, within hours of vaccination with Influenza vaccine unspecified, the subject experienced hard to breath, extensive swelling of vaccinated limb, red around injection site, injection site warmth, and pain around injection site. When the subject experienced the difficulty breathing, she reported that "she thought it might be her asthma so she tried her inhaler but it did not help." It was unclear which inhaler the subject used to treat the difficulty breathing; however, the subject reported a concurrent inhaler of Proair. The subject "took some Benadryl and went to bed." On 18 October 2013, when the subject "woke up. she had difficulty breathing again, so she took more Benadryl." The pain and swelling at the injection site had "continued to get worse throughout the day. The injection site swelling was "swollen up 6 inches [152.4 millimeters] around the site." The subject has consulted with her healthcare professional but has not been evaluated at the time of reporting. The subject will consider going to the emergency room if "it continues to get worse." On 18 October 2013, within the same day as vaccination with Influenza vaccine unspecified, the subject experienced nausea. The subject reported that "she started to have nausea today which is just constant." The subject was treated with inhaler (Unknown bronchial inhaler) and Benadryl. At the time of reporting on 18 October 2013 at 13:55, the difficulty breathing had resolved. The subject reported that "she had not had difficulty breathing since this morning." At the time of reporting the events of extensive swelling of the vaccinated limb, red around injection site, injection site warmth, and pain around injection site were worse. At the time of reporting, the outcome of event of nausea was unresolved.
Since getting the vaccination my menstruation cycle has completely stopped.  I have not had a period since getting the vaccine.
Apparent apneic episode and emesis and fussy. Temp. to 100.4 hours after vaccines (unclear how temp. taken). Similar fever at 2+ 4 mos. old with similar vaccines (Not Flu).
6/5/03 Pt refused to move his right arm. Node in axilla swollen about the size of a quarter. Awoke in night x4. Given Tylenol. Has cold symptoms. Recent ear infection - Mom concerned about another ear infection. Didn't eat well that day but better appetite the next day. 6/6/03 Took him to PMD - ears OK. They had her hot pack it and give Ibuprofen. Swelling down. Child better.
I got vaccine tonight ~1750. I felt fine immediately after and stayed for the recommended 15 minutes.  During my drive home, ~20 minutes, I had some expiratory wheezing and a sensation of something in my throat. No angioedema or swelling.  No skin symptoms.  This was mild but made me think twice so I drove back to the er.  The wheezing resolved, but I felt like I was going to faint with hot flushing and nausea in the parking lot.  I didn?t go in because things seemed better and my stomach was turning like I was going to have diarrhea.  Since the wheezing was gone, I decided against going in.  I stayed in the parking lot for ~ 15 minutes and feeling of unease and presyncope waxed and waned, but eased.  I continued with some nausea. I had waves of nausea, chills, flushing, and presyncope. The wheezing didn?t return. No tachycardia.  I had chills and nausea on the drive home and at home. Took Tylenol and Pepcid when I got home and feel absolutely fine now after ~2 hours of fluctuating nausea, chills and sense of unease/anxiety.  None were as severe as they were when I was in the parking lot.  Throughout, I didn?t have high or low heart rate.  After 8 pm or so, I feel just fine. I have zero symptoms now.
Severe abdominal pain, severe lightheadedness, vomiting continued for 20-30 minutes and quickly subsided to slight abdominal discomfort; checked at ER, released on bland diet.
administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported.  Date the vial was initially stored in the refrigerator reported as unknown. Number of doses/vials was reported as 102 doses from LOT 026C21A. Expiration date was reported as 24-Oct-2021. The vial did not undergo any temperature excursions.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow up contains non significant information.
Patient complained of itching at site of administration within 15 to 20 minutes post-vaccination.
DIARRHEA; VOMITING; CHILLS; FATIGUE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042a21a, and expiry: 21-JUN-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 25-APR-2021, the subject experienced diarrhea. On 25-APR-2021, the subject experienced vomiting. On 25-APR-2021, the subject experienced chills. On 25-APR-2021, the subject experienced fatigue. On 25-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, fatigue, nausea, diarrhea and vomiting was not reported. This report was non-serious.
Numbing HA to bilateral occipital areas 3-4/10 Narrative:
pt recv vax;felt hot & swollen;noticed rash,redness down arm & itching;referred to er;meds given;to apply warm compress;
Discomfort when raising arm; Short of breath when going up stairs; Wobbly; Woozy, light headed, dizzy; Chills; Pain on shoulder; Pain on neck; Pain on side; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Short of breath when going up stairs), GAIT DISTURBANCE (Wobbly), LIMB DISCOMFORT (Discomfort when raising arm), NECK PAIN (Pain on neck) and PAIN (Pain on side) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure (Taking medication for blood pressure.) and Type 2 diabetes mellitus (Taking medication for t2 diabetes.).    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced NECK PAIN (Pain on neck), PAIN (Pain on side) and ARTHRALGIA (Pain on shoulder). On 27-Feb-2021, the patient experienced DYSPNOEA (Short of breath when going up stairs), GAIT DISTURBANCE (Wobbly), DIZZINESS (Woozy, light headed, dizzy) and CHILLS (Chills). In March 2021, the patient experienced LIMB DISCOMFORT (Discomfort when raising arm). At the time of the report, DYSPNOEA (Short of breath when going up stairs), GAIT DISTURBANCE (Wobbly), LIMB DISCOMFORT (Discomfort when raising arm), NECK PAIN (Pain on neck), PAIN (Pain on side), DIZZINESS (Woozy, light headed, dizzy), ARTHRALGIA (Pain on shoulder) and CHILLS (Chills) outcome was unknown.            Concomitant medications reported were blood pressure, type 2 diabetes medications.  Treatment information included pain pills.
some patients experienced tachycardia; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (some patients experienced tachycardia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TACHYCARDIA (some patients experienced tachycardia). At the time of the report, TACHYCARDIA (some patients experienced tachycardia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
a little bit muscle soreness; This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (a little bit muscle soreness) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Zemplar                                                        Paricalcitol, ROMOSOZUMAB and Minivelle                                                      Estradiol for an unknown indication.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (a little bit muscle soreness). On 12-Feb-2021, MYALGIA (a little bit muscle soreness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information has been received from a company representative as reported by a nurse concerning a female (age not reported) who in approximately May 2007 "within the last couple of weeks", was vaccinated with a dose of Gardasil (lot# not provided). In approximately May 2007 'within the last two weeks or so", the patient experienced vomiting and fainting after receiving the first dose of the vaccine. The patient was hospitalized for about 5 days. Liver enzyme tests were performed indicating that "she may have some liver enzyme elevation." The patient was complaining about GI upset. Subsequently the patient recovered. There was no product quality complaint involved. No further information is available.
As I was eating my lunch I became lightheaded and my heart was beating hard/fast I began thinking I was going to pass out I called 911.
Site redness, swelling, and itching that started 8 days post injection. Fever 100.0 that started 8 days post injection.
Numbness/dull throbbing in left hip at first then moving down leg to foot.  Left leg from thigh to foot feeling throbbing/numbness
tingling of the lips; Joint pain; muscle pain; felt dizzy after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt dizzy after vaccination), PARAESTHESIA ORAL (tingling of the lips), ARTHRALGIA (Joint pain) and MYALGIA (muscle pain) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced DIZZINESS (felt dizzy after vaccination). On 12-Apr-2021, the patient experienced PARAESTHESIA ORAL (tingling of the lips), ARTHRALGIA (Joint pain) and MYALGIA (muscle pain). The patient was treated with IBUPROFEN at a dose of 600 mg. On 10-Apr-2021, DIZZINESS (felt dizzy after vaccination) had resolved. At the time of the report, PARAESTHESIA ORAL (tingling of the lips), ARTHRALGIA (Joint pain) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
rash on the antecubital areas;lower arms & thighs that started 2 days ago;rash is red maculo-papular & itchy;no rash on face & red;rest of exam nl;
Difficulty breathing; Tightness of chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Tightness of chest) and DYSPNOEA (Difficulty breathing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (Tightness of chest) and DYSPNOEA (Difficulty breathing). At the time of the report, CHEST DISCOMFORT (Tightness of chest) and DYSPNOEA (Difficulty breathing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.
Child developed hives on face on Wednesday morning, 7/20/22, 1 day following receiving Covid19 vaccination. By Thursday evening, 7/21/22, patient was covered from head to toe in hives. Patient was evaluated in clinic On Friday, 7/22/22, and noted to have rash consistent with urticaria multiforme. Mother was instructed to use antihistamine and topical steroid for symptom relief.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Mar2022 at 15:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 71 years intramuscular, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Paroxysmal AFIB" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL, start date: 16Aug2021.   The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19.The patient took anti-viral drug Paxlovid from 22Jul2022 to 23Jul2022 for COVID-19 treatment.Other medication was received in 2weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever to 101 during the evening of flu imm. No headache. C/O back discomfort.
Per mother December 17th and 18th patient had vomiting, diarrhea, fever of 101, and increased heart rate. Mom administered 2 puffs Albuterol inhaler, Tylenol, and Pedialyte. Mom took patient to Emergency Room. A Strep test throat culture was obtained and negative. There was no treatment given per mom. On December 19th at 8:00 AM, patient better per mom.
Baby had excessive crying (high pitched cry), within 24 hours of the Pediarix vaccine. Doctor treatment needed.
Mild Chills 12 - 15 hours after vaccine. Morning of day 2 after vaccine became of swollen and tender lymph node in armpit of vaccinated arm.
At approximately 5:15 pm on 9/19/2021. I administered the 1st dose in the Pfizer COVID-19 series to the patient. Following a review of the consent form and after questioning the patient, who denies any previous reactions to any other vaccines or medications, I administered the vaccine. At approximately 5:34 pm during the patient's waiting period following the vaccination they asked if it was normal to "feel hot" and be sweating after the vaccine. I immediately went over to the patient and informed them that this was not a normal reaction to the vaccine and that it likely could be due to a potential allergic reaction. The patient remained conscious and was able to clearly voice their symptoms. They described their reaction as feeling hot all over, and sweating, accompanied by a feeling like they might throw up or pass out and generalized weakness. I took the patients blood pressure and pulse with the kit located in the pharmacy at 5:26pm and got a reading of 92/45 with a pulse of 68. I informed the patient that their pulse was normal, but their blood pressure was low and advised them not to try to stand. I checked the patients arms and around the injection site and found no swelling, warmth or erythema present. Patient denied any swelling or troubles with breathing. I took a temperature at 5:34 pm and got a result of 97.6 via a forehead thermometer. At this time patient stated that they no longer felt hot all over but just weak and a little shaky and felt that they may be getting better and acknowledged that their anxiety of the situation may be contributing to the shakiness. After confirming no contraindications to Benadryl and providing patient counseling, I offered a 25 mg dose of Benadryl to the patient as an antihistamine to help with the reaction, which the patient accepted and took at 5:46 pm. The patient continued to state that they still feel a little shaky but feel like they are getting better slowly. At 5:56 pm I rechecked the patient's BP and got 125/88 and a pulse of 77. At this time patient stated that they have started to feel a lot better, and that they were no longer shaky and felt like they were returning to normal. Again, I reinforced that they should follow up with their doctor regarding their reaction to determine if they still want to go ahead with the second dose and I informed the patient that my recommendation would be to NOT get the second dose, due to the risk of an anaphylactic reaction. Patient understood and verbalized consent for me to provide her information to the CDC in this VAERS report. I also asked the patient if there was someone that could take them home, or if they needed transportation when they felt safe to leave and advised them not to drive home. They stated that they called someone who is on their way to pick them up. Patient confirmed that they will follow up with their doctor regarding their reaction and will let us know if they experience any further reactions at a later time. Wished patient well and made sure they were able to safely get to their feet when their ride arrived and they safely left the pharmacy at 6:14 pm.
14AUG97 pt was taken to ER d/t sz lasting about 30min;pt cont to run fever;pt was seen by MD 16AUG97;mom was told by MD it was a rxn to vax;
Minutes after receiving the vaccine, the patient started feeling dizzy and had blurred vision. He also started vomiting after  drinking water. The patient recovered quickly after the arrival of the EMS and didn't require any medical assistance.
Had the vaccine Friday morning.   No problems except for headache & sore arm Fri & all day Sat.   Woke up Sunday morning with tenderness & edema left side of my face near my left eye.   It is now 4pm and the edema is still localized to the same area.
Fever, 3in redness and swelling around site.  Left arm sore/stiff, painful.